323 related articles for article (PubMed ID: 22871556)
1. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.
Rutten CE; van Luxemburg-Heijs SA; Halkes CJ; van Bergen CA; Marijt EW; Oudshoorn M; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jan; 19(1):40-8. PubMed ID: 22871556
[TBL] [Abstract][Full Text] [Related]
2. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
[TBL] [Abstract][Full Text] [Related]
3. HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.
Stevanovic S; van Bergen CA; van Luxemburg-Heijs SA; van der Zouwen B; Jordanova ES; Kruisselbrink AB; van de Meent M; Harskamp JC; Claas FH; Marijt EW; Zwaginga JJ; Halkes CJ; Jedema I; Griffioen M; Falkenburg JH
Blood; 2013 Sep; 122(11):1963-73. PubMed ID: 23777765
[TBL] [Abstract][Full Text] [Related]
4. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH
Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
7. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
8. Mismatched HLA-DRB3 Can Induce a Potent Immune Response After HLA 10/10 Matched Stem Cell Transplantation.
van Balen P; van Luxemburg-Heijs SAP; van de Meent M; van Bergen CAM; Halkes CJM; Jedema I; Falkenburg JHF
Transplantation; 2017 Dec; 101(12):2850-2854. PubMed ID: 28252558
[TBL] [Abstract][Full Text] [Related]
9. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
10. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
12. The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells.
Laghmouchi A; Hoogstraten C; van Balen P; Falkenburg JHF; Jedema I
Haematologica; 2019 Jan; 104(1):197-206. PubMed ID: 30237261
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
14. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
[TBL] [Abstract][Full Text] [Related]
15. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
18. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.
Rutten CE; van Luxemburg-Heijs SA; van der Meijden ED; Griffioen M; Oudshoorn M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1282-92. PubMed ID: 20350610
[TBL] [Abstract][Full Text] [Related]
20. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
